Nonrulemaking

Request that the FDA determine whether DDAVP (desmopressin acetate) Nasal Spray, 0.01 mg/Spray (Needs No Refrigeration), Product No. 003 approved under New Drug Application (NDA) number 017922, held by Ferring Pharmaceuticals, Inc., has been voluntarily withdrawn for reasons of safety or effectiveness.

Documents
2
Total comments
0
all analyzed
Comment status
Open
Last activity
In this docket

Documents

Rules, notices, and supporting material — the primary rule pinned first.

📄 Primary document